MUSTN1
Musculoskeletal embryonic nuclear protein 1
Also known as: MSTN1_HUMAN, Mustang
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IVN3
- Gene
- MUSTN1
- Ensembl
- ENSG00000272573
- Chromosome
- 3
- Canonical length
- 82 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be involved in glucose homeostasis and positive regulation of myoblast differentiation. Predicted to act upstream of or within positive regulation of chondrocyte differentiation; positive regulation of chondrocyte proliferation; and positive regulation of macromolecule biosynthetic process. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
82 residues, UniProt reviewed canonical sequence.
>Q8IVN3|MUSTN1
1 MSQAGAQEAP IKKKRPPVKD EDLKGARGNL TKNQEIKSKT YQVMRECEQA GSAAPSVFSR
61 TRTGTETVFE KPKAGPTKSV FGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MUSTN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 1,711 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 1,711 nTPM
- blood vessel: 1,491 nTPM
- tongue: 285 nTPM
- heart muscle: 200 nTPM
- adipose tissue: 132 nTPM
- cervix: 114 nTPM
Single-cell type
- vascular smooth muscle cells: 25 nCPM
- pericytes: 14 nCPM
- thymic myoid cells: 4.1 nCPM
- smooth muscle cells: 2.7 nCPM
- astrocytes: 1.9 nCPM
- bergmann glia: 1.2 nCPM
Immune cell
- neutrophil: 0.3 nTPM
- MAIT T-cell: 0.2 nTPM
- memory B-cell: 0.1 nTPM
- T-reg: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- basal ganglia: 53 nTPM
- thalamus: 51 nTPM
- cerebral cortex: 48 nTPM
- pons: 35 nTPM
- medulla oblongata: 28 nTPM
- midbrain: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.2
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chondrocyte differentiation
- chondrocyte proliferation
- embryonic limb morphogenesis
- glucose homeostasis
- muscle organ development
- positive regulation of chondrocyte differentiation
- positive regulation of chondrocyte proliferation
- positive regulation of gene expression
- positive regulation of myoblast differentiation
- positive regulation of proteoglycan biosynthetic process
- tissue regeneration
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Musculoskeletal embryonic nuclear protein 1
- Musculoskeletal, temporally activated-embryonic nuclear protein 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MUSTN1 as an antibody target. Whether an autoantibody or antibody against MUSTN1 could matter depends on whether native MUSTN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MUSTN1 is annotated as secreted, so native MUSTN1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MUSTN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...